Epitope Mapping

½ÃÇè¼Ò°³

Epitope´Â Ç×ü(Antibody)¿¡ ÀÇÇØ ÀνĵǴ ±¸Á¶ÀÎ Ç׿ø°áÁ¤ºÎÀÌ´Ù. Ç׿ø(Antigen) ºÐÀÚÀÇ ¾î´À À§Ä¡(Amino acid sequence)¿¡¼­ Ç×ü¿Í °áÇÕÇÏ´ÂÁö ¾Ë¾Æº¸±â À§ÇØ ºÐÀÚ¸¦ ¿©·¯°¡Áö ¹æ¹ýÀ¸·Î ´ÜÆíÈ­ ÇÏ¿© Á¶»çÇÏ´Â ¹æ¹ýÀÌ´Ù. Epitope Mapping ºÐ¼®¹æ¹ýÀº Covalent labeling, Cross Link, Immuno-affinity peptide screening ¹ýÀ» ÅëÇØ Epitope À§Ä¡¸¦ È®ÀÎÇÑ´Ù. 3 °¡Áö °¢ÀÚ ´Ù¸¥ ºÐ¼®À» ÅëÇØ Epitope regionÀ» È®ÀÎÇÑ´Ù. Ç×ü ´Ü¹éÁúÀÇ Linear type °ú Conformational type ¸ðµÎ È®ÀÎ °¡´ÉÇÑ ¹æ¹ýÀÌ´Ù.

Epitope Mapping Process

»ùÇÃ

  • Biosimilar
  • Biobetter
  • Antibody
  • Protein-protein interaction

½ÃÇè ¹æ¹ý

<½ÃÇè°á°ú>

1) DEPC labeling

2) Chemical cross link

3) Immuno-affinity peptide screening

Unbinding fraction Elution fraction (Area) sequence
Frag# Res Area 1st 2nd 3rd
T14 180-188 1,291,000,000 810,600 8,799,000 11,950,000 TAAGGPVTSR
T16 235-243 799,700,000 2,995,500 3,023,000 2,819,000 VDDPPQNGDNDR
T21 281-288 66,900,000 1,425,000 1,232,000 1,367,000 WQCQLYQGER
°æ±âµµ ¼ö¿ø½Ã Àå¾È±¸ Àå¾È·Î496¹ø±æ 93(À̸ñµ¿) 2Ãþ  (ÁÖ)ÃæÀΰúÇÐ   ´ëÇ¥ÀüÈ­ : 031.241.6413   FAX : 031.241.6424
COPYRIGHT 2015 CHOONGIN ALL RIGHTS RESERVED.